The emerging model, named PLAN-B, comprised ten baseline parameters: cirrhosis, age, platelet count, entecavir/tenofovir, sex, serum ALT and HBV-DNA, albumin and bilirubin levels, and HBeAg status, and it showed significant superiority over the previous models in both validation cohorts [60]. The gene discussed is ALB; the disease is Cirrhosis.